(Lexington, KY). Mouse RASAL1 antibodies were obtained from Santa Cruz Biotechnology (Santa Cruz, CA). The Halo-tag antibody was purchased from Promega.
The Flag (DYKDDDDK)-tag antibody was purchased from Wako.
Immunoprecipitation
For immunoprecipitation, cell lysates were precipitated by incubation with anti-FLAG M2 agarose (Sigma) for 8 h, or by incubation with anti-MKL1 or anti-SRF antibodies, followed by addition of protein A/G agarose (Santa Cruz) overnight. Cell extracts were prepared as described previously (3) .
Western blotting
Western blotting was conducted as described previously (3) .
Plasmids
The human RASAL1 expression plasmid (pcDNA3.1-RSAL1) was constructed as described previously (2) . RASAL1 cDNA was subcloned into pCDH-puromycin vector (System Biosciences, Mountain View, CA) for lentivirus production by an infusion method (Clontech) at EcoRI site using the following primers: 5'-TAG AGC TAG CGA ATT CAC CTG AGC GCC CTT CTG C-3' and 5'-ATT TAA ATT CGA ATT CCC TGG CTC TTG CTC CTC C-3'. For Flag-tagged RASAL1-expressing plasmid construction, the primers used were 5'-ATC GGA TCC GCG GCC GCG CCG CCA TGG ACT ACA AGG ACG ACG ACG ACA AGG ACT ACA AGG ACG ACG ACG ACA AGA TGG CCA AGA GCA GCT C-3' and 5'-AGA TCC TTC GCG GCC GCA TTT CCT TAG GGG CCA AGG G-3'. The Halo-tagged AGTR1 clone was purchased from Promega. PCR-amplified AGTR1 cDNA from the Halo-tagged AGTR1 clone was inserted into the pCDH-neomycin vector (System Biosciences) at the NotI site to produce AGTR1-expressing lentiviruses. The primers used were 5'-ATC GGA TCC GCG GCC GCA CCA TGA TTC TCA ACT CTT CTA C-3' and 5'-CAG ATC CTT GCG GCC GCT CAC TCA ACC TCA AAA CAT GG-3'. The mouse RASAL1-expressing plasmid was constructed by cloning of mouse RASAL1 cDNA into the pcDNA3-HA vector.
Lentivirus production and transduction
cDNA-expressing lentiviruses were produced by transfection of a cDNA-expressing pCDH vector and pPACKH1 packaging plasmid mix (System Biosciences) into 293T cells. After 48 h, virus-containing supernatants were collected and viral particles were concentrated using PEG-it Virus Precipitation Solution according to the manufacturer's protocol (System Biosciences). To generate stable RASAL1-and AGTR1-overexpressing cells, LX2 cells were transduced with RASAL1-or AGTR1-expressing constructs containing lentiviral particles, followed by selection with 2 g/mL puromycin or 600 g/mL neomycin.
Reporter assays
Dual reporter assays using pGL4-TK, a Renilla luciferase construct as a control, were performed basically as described previously (4) . The series of -SMA promoter-driven reporters was kindly provided by Dr. Manabe (5) . SRF-RE luc, containing a firefly luciferase gene driven by a TATA box plus five repeats of the binding sites for SRF (GTCCATATTAGGAC), was obtained from Stratagene (La Jolla, CA). An AGTR1 6 promoter-driven reporter construct was purchased from GeneCopoeia (Rockville, MD), and was used according to the manufacturer's protocol.
Chemical compound screening
The SCADS Inhibitor Kit, an inhibitor set consisting of 380 chemical inhibitors with 
Immunocytochemistry
Cells were seeded in the chamber slides (Nalge Nunc, Naperville, IL). The next day, cells were fixed with 4% paraformaldehyde and permeabilized with 0.5% Triton-X100.
Fixed cells were incubated with primary antibodies for 60 min at room temperature, followed by incubation with Alexa Flour 488-or 555-conjugated secondary antibodies (Invitrogen, Carlsbad, CA) for 60 min at room temperature. Slides were mounted using VectaShield with DAPI (Vector Labs, Burlingame, CA). To examine the effects of 7 TGF-, cells were incubated with serum-free DMEM for 24 h and treated with 10 ng/mL TGF- for 60 min before fixation.
Immnohistochemistry
Immnohistochemistry was performed as described previously (3). The area of fibrosis was determined using the ImageJ software.
Ras, RhoA, and Gi activities
Ras and RhoA activities were measured using the Ras and RhoA Activation Pull-down Biochem Kit from Cytoskeleton (Denver, CO) according to the manufacturer's protocols. Briefly, after washing the cells with ice cold PBS, they were dissolved with cell lysis buffer and harvested using a cell scraper. Cell lysates were transferred to sample tubes and centrifuged (10,000 rpm, 4°C, 2 min). GST-tagged Ras binding domain (RBD) of Raf protein beads for Ras activity and GST-tagged Rhotekin protein beads for RhoA activity were added to the equivalent protein amounts of lysate and incubated at 4°C on a rotator for 1 h. The beads were pelleted by centrifugation (3,000g, 1 min, 4°C), and were washed with 500 L of wash buffer and pelleted by centrifugation (3,000g, 3 min, 4°C). After the supernatant was removed carefully and 2× sample buffer was added, the beads samples were boiled for 2 min. Activities of Gαi were measured using the Gαi activation kit from Abcam based on immunoprecipitation using an anti-active Gαi monoclonal antibody according to the manufacturer's protocol.
The amounts of GTP-bound Ras and RhoA, and active Gi proteins, were determined by Western blotting using the specific antibodies provided.
PKA and PKC kinase assay
PKA and PKC activities were determined using PKA and PKC kinase activity assay kits obtained from Abcam (#ab139435 and #ab139437, respectively) based on ELISA, according to the manufacturer's protocol. Briefly, wells containing PKA or PKC substrate peptides were soaked with Kinase Assay Dilution Buffer for 10 min at room temperature and the buffer was aspirated. Samples were added to the appropriate wells and diluted ATP was added to each well to initiate the reaction. The plate was incubated at 30°C for 90 min, and then the liquid was aspirated to stop the reaction. Antibodies against phosphor-specific substrate peptides were added to each well and incubated at room temperature for 60 min, and then liquid was aspirated from all wells. Wells were washed with wash buffer four times. Anti-rabbit IgG:HRP conjugate was added to each well and the plate was incubated at room temperature for 30 min. Wells were then washed. TMB Substrate Solution was added to each well and the plate was incubated at room temperature for 30 min. The Stop Solution was added to each well and the absorbance at 450-nm wavelength was measured using a microplate reader.
Quantitative real-time PCR (qRT-PCR)
The Fibrosis RT 2 Profiler PCR Array was obtained from QIAGEN (Hilden, Germany) and used for qRT-PCR analysis. qRT-PCR was performed as described previously (3).
Briefly, total RNA was isolated from cells using TRIzol Reagent (Invitrogen, Carlsbad, CA). cDNA was synthesized from RNA using the SuperScript III First-Strand Synthesis System (Invitrogen). Quantitative PCR was performed using the TaqMan gene expression system with Sybr Green (Applied Biosystems, Foster City, CA). All values were normalized to the level of mRNA of the housekeeping gene, GAPDH, and the 9 relative expression was calculated according to the C T method: C T = C Tsample -C Tgapdh .
Cell growth assays
Cells were plated in 48-well plates at a density of 1×10 4 Halo-tagged AGTR1-expressing plasmid. Cell lysates without transfection were used as a control. Flag-tagged RASAL1 was immunoprecipitated using anti-Flag agarose.
Agarose-conjugated anti-mouse IgG was also used as a negative control.
Co-precipitated proteins were blotted using antibodies against the indicated proteins. Of the total cell lysates, 5% were loaded as an input control. Representative results from three independent experiments are shown. b, Activities of PKC in control, RASAL1-expressing, and RASAL1 + AGTR1-coexpressing LX2 cell lysates were measured by ELISA using phosphor-specific antibodies against PKC substrate peptides.
Data represent the means ± SD of three independent experiments. c, RASAL1 had no effect on the phosphorylation of JAK2. The JAK2 phosphorylation status in control d, The degree of liver inflammation was similar in control and RASAL1-deficient mice.
Biochemical parameters reflecting liver inflammation were measured in sera at 8 weeks 
